(Q31271107)

1 July 2017

1 reference

title

Proton magnetic resonance spectroscopy in portal-systemic encephalopathy (English)

1 reference

1 July 2017

Köstler H

1

1 reference

1 July 2017

publication date

1 December 1998

1 reference

1 July 2017

published in

Metabolic Brain Disease

1 reference

1 July 2017

volume

13

1 reference

1 July 2017

issue

4

1 reference

1 July 2017

page(s)

291-301

1 reference

Biochemical considerations in1H spectroscopy. Glutamate and glutamine;Myo-inositol and related metabolites

1 July 2017

cites work

1 reference

12 December 2020

Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy

1 reference

12 December 2020

Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.

1 reference

12 December 2020

NMR spectroscopy in portal-systemic encephalopathy: are we there yet?

1 reference

12 December 2020

Synaptic transmission in ammonia intoxication

1 reference

12 December 2020

Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy

1 reference

12 December 2020

Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver disease

1 reference

12 December 2020

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

1 reference

12 December 2020

The basal ganglia and portal-systemic encephalopathy

1 reference

12 December 2020

Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy.

1 reference

12 December 2020

What the clinician can learn from MR glutamine/glutamate assays

1 reference

12 December 2020

MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration?

1 reference

12 December 2020

Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations

1 reference

12 December 2020

Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy

1 reference

12 December 2020

Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy

1 reference

12 December 2020

Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols

1 reference

12 December 2020

[Clinical uses of proton magnetic resonance spectroscopy of the brain]

1 reference

12 December 2020

Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging

1 reference

12 December 2020

Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study

1 reference

12 December 2020

MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status

1 reference

12 December 2020

Clinical applications of magnetic resonance spectroscopy.

1 reference

12 December 2020

Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy

1 reference

12 December 2020

Localized proton MR spectroscopy. A non-invasive insight into brain metabolism

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis

1 reference

12 December 2020

Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images

1 reference

12 December 2020

Astrocyte swelling in liver failure: role of glutamine and benzodiazepines

1 reference

12 December 2020

Proton MR spectroscopy for diagnosing hepatic encephalopathy?

1 reference

12 December 2020

Noninvasive neuroinvestigation in liver disease

1 reference

12 December 2020

Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure

1 reference

12 December 2020

Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy

1 reference

12 December 2020

The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy

1 reference

12 December 2020

Spatial localization in NMR spectroscopy in vivo

1 reference

12 December 2020

Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities

1 reference

12 December 2020

Acquired hepatocerebral degeneration: MR similarity with Wilson disease

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020632708154

1 reference

Dimensions Publication ID

1 July 2017

1028281229

0 references

1 reference